Gilead Reports Positive Results for Lenacapavir, Semiannual HIV Treatment

August 01, 2021

The favorable results could mean a new treatment option for patients with HIV whose disease has not responded to other treatments. They may also be another step toward HIV treatment that doesn’t depend on daily pills.